3utz
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3utz.png|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3utz", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3utz| PDB=3utz | SCENE= }} | {{STRUCTURE_3utz| PDB=3utz | SCENE= }} | ||
| - | |||
===Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential=== | ===Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential=== | ||
| - | |||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_22198278}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 22198278 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_22198278}} | {{ABSTRACT_PUBMED_22198278}} | ||
| Line 22: | Line 7: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:022198278</ref><references group="xtra"/> | + | <ref group="xtra">PMID:022198278</ref><references group="xtra"/><references/> |
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
[[Category: Arad-Yellin, R.]] | [[Category: Arad-Yellin, R.]] | ||
Revision as of 06:13, 2 October 2013
Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential
Template:ABSTRACT PUBMED 22198278
About this Structure
3utz is a 6 chain structure with sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
- Sela-Passwell N, Kikkeri R, Dym O, Rozenberg H, Margalit R, Arad-Yellin R, Eisenstein M, Brenner O, Shoham T, Danon T, Shanzer A, Sagi I. Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential. Nat Med. 2011 Dec 25;18(1):143-7. doi: 10.1038/nm.2582. PMID:22198278 doi:10.1038/nm.2582
Categories: Escherichia coli | Arad-Yellin, R. | Brenner, O. | Danon, T. | Dym, O. | Eisenstein, M. | ISPC, Israel Structural Proteomics Center. | Kikkeri, R | Margalit, R | Rozenberg, H | Sagi, I. | Sela-Passwell, N. | Shanzer, A. | Shoham, T. | Fab domain | Immune system | ISPC | Israel Structural Proteomics Center | Structural genomic
